discovery make human vaccine
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Twitter ~ Facebook
Home / Technology News / 2009 / March 2009 / March 3, 2009
New discovery to make human vaccine against bird flu a reality
RSS / Print / Comments

Bird Flu

Why bird flu didn't become a pandemic

Dead pigeons, boa constrictor among top weird finds at UK airports

Frost & Sullivan: Medical Waste Finds Growth in Malaysia's Robust Healthcare System

More on Bird Flu

Technology News

Squeezable cell phone to give you status info without having to look at it
Scientists have developed a squeezable cellphone - SqueezeBlock - using tiny motors built into the casing to mimic the behaviour of a spring. ANI

Airplanes that also travel in space to be 'the holy grail' of aeronautics
A British firm is working on an airplane that would also travel in space. ANI

Was Oz-Indian scientist first to discover recently found Earth-like planet?
The recent discovery of Earth-like planet caused a tizzy in the science world, but many are still sceptical of the claim. ANI

New discovery to make human vaccine against bird flu a reality

Researchers at University of Melbourne claim that they are closer to developing a human vaccine for avian influenza, commonly known as bird flu, after making a new discovery.


Washington, Mar 3 : Researchers at University of Melbourne claim that they are closer to developing a human vaccine for avian influenza, commonly known as bird flu, after making a new discovery.

They have found that boosting T cell immunity could better protect humans from bird flu pandemic.

"The 'Killer T cell' is the hit-man of the immune system. It is able to locate and destroy virus-infected cells in our body helping rid us of infection," said Associate Professor Stephen Turner, from the Department of Microbiology and Immunology at the University of Melbourne who is a lead author on the paper.

"Unfortunately, current influenza vaccines are poor at inducing killer T cell immunity. Therefore, we wanted to see if we could improve the current vaccine formulation to induce killer T cells after vaccination.

"We added a compound, known to increase immunity, to the flu vaccine in an animal model. The addition of this compound promoted significant generation of potent killer T cell immunity and provided protection from infection.

"The significance of these findings is that rather than having to design a new vaccine altogether, we can improve current flu vaccines by adding this potent immune modulator.

"With appropriate clinical testing, we could see improvements to current vaccines within the next five years," Turner added.

Turner said that the key to vaccine effectiveness was ensuring a match between the vaccine and the current circulating flu strain.

However, the spike proteins varied over the course of a flu season rendering the current vaccine ineffective. As such, the vaccine needs to be updated every year to match the likely strain for that winter.

"It is a different situation for influenza pandemics. Pandemics arise due to the introduction of a new influenza virus into human circulation. As such, there is little or no pre-existing immunity to the bird flu virus enabling it to spread rapidly," Turner said.

"'Killer' T cells recognise components that are conserved between different influenza viruses. Therefore, a vaccine strategy that induced killer T cells pre-emptively would provide protection from a potential pandemic," he added.

The study has been published in the prestigious Proceedings of the National Academy of Sciences.

ANI

Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us